triazoles has been researched along with vancomycin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Hassawi, N; Ali, AA; Phillips, OA; Udo, EE | 1 |
| Colson, YL; Marty, FM; Paul, S | 1 |
| Cleveland, KO; Lacasse, A | 1 |
| Bahador, A; Dehghani, M; Gholami, S; Hashemi, SB; Janghorban, P; Kakaei, F; Kazemi, K; Malek-Hosseini, SA; Nikeghbalian, S; Salahi, H; Shishegar, M | 1 |
| Castanheira, M; Jones, RN; Woosley, LN | 1 |
| Beral, L; Desbois, N; Donnio, A; Guyomarch, J; Merle, H; Olive, C; Theodose, R; van Nuoï, DN | 1 |
| Bergmeier, SC; Bessette, BA; Kusche, BR; McMills, MC; Phillips, JB; Priestley, ND; Smith, AE; Swain, PW; Wright, DL | 1 |
| Kemmink, J; Liskamp, RM; Rijkers, DT; Zhang, J | 1 |
| Krishnan, T; Rishi, P | 1 |
| Bayer, A; French, SW; Gebremariam, T; Ibrahim, AS; Lee, H; Luo, G; Spellberg, B; Xiong, YQ | 1 |
| Akkapeddi, P; Haldar, J; Manjunath, GB; Yarlagadda, V | 1 |
| Davis, K; Fabian, E; Greenhaw, J; Groeters, S; Herold, M; Kamp, H; Looser, R; Marxfeld, H; Mattes, W; Mellert, W; Moeller, N; Montoya-Parra, G; Prokoudine, A; Strauss, V; van Ravenzwaay, B; Walk, T | 1 |
| Moses, JE; Sharpless, KB; Silverman, SM | 1 |
| Fleming, ME; Gordon, WT; Jessie, EM; Khan, M; Malone, DL; Murray, CK; Potter, BK; Rodriguez, CJ; Shackelford, SA; Tribble, DR | 1 |
| Fernandez, E; Makar, G; Perz, A; Rafferty, W; Weinstock, J | 1 |
| Deng, Q; Wang, Y; Wang, Z; Wen, Z; Xiong, Y; Xu, G; Yu, Z; Zheng, J | 1 |
1 review(s) available for triazoles and vancomycin
| Article | Year |
|---|---|
Trichosporon mucoides fungemia in a liver transplant recipient: case report and review.
Topics: Antifungal Agents; Enterococcus faecium; Fatal Outcome; Fungemia; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycoses; Peritonitis; Postoperative Complications; Tacrolimus; Triazoles; Trichosporon; Vancomycin; Vancomycin Resistance | 2009 |
15 other study(ies) available for triazoles and vancomycin
| Article | Year |
|---|---|
Synthesis and antibacterial activity of 5-substituted oxazolidinones.
Topics: Acetamides; Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Structure-Activity Relationship; Triazoles; Vancomycin | 2003 |
Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Bone Marrow Transplantation; Cefepime; Cephalosporins; Combined Modality Therapy; Cunninghamella; Daunorubicin; Drug Resistance, Multiple, Fungal; Female; Humans; Imatinib Mesylate; Immunocompromised Host; Lung Diseases, Fungal; Middle Aged; Neutropenia; Piperazines; Pneumonectomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Transplantation Conditioning; Triazoles; Vancomycin; Vincristine; Voriconazole; Zygomycosis | 2006 |
Endogenous Aspergillus endophthalmitis occurring after liver transplantation: a case report.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Aspergillus; Endophthalmitis; Eye Enucleation; Humans; Liver Cirrhosis; Liver Transplantation; Male; Polymerase Chain Reaction; Pyrimidines; Triazoles; Vancomycin; Voriconazole; Young Adult | 2009 |
CEM-101 activity against Gram-positive organisms.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2010 |
[Infectious keratitis and cosmetic lenses: a five-case retrospective study].
Topics: Abscess; Acanthamoeba Keratitis; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Antifungal Agents; Benzamidines; Biguanides; Blindness; Contact Lenses; Corneal Opacity; Corneal Surgery, Laser; Female; Gentamicins; Humans; Keratitis; Middle Aged; Pseudomonas Infections; Pyrimidines; Retrospective Studies; Risk Factors; Serratia Infections; Staphylococcal Infections; Ticarcillin; Triazoles; Vancomycin; Voriconazole; Young Adult | 2010 |
Natural product derivatives with bactericidal activity against Gram-positive pathogens including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
Topics: Anti-Bacterial Agents; Biological Products; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacteria; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Stereoisomerism; Triazoles; Vancomycin | 2010 |
Synthesis of 1,5-triazole bridged vancomycin CDE-ring bicyclic mimics using RuAAC macrocyclization.
Topics: Alkynes; Azides; Bridged Bicyclo Compounds; Cyclization; Models, Molecular; Molecular Structure; Organometallic Compounds; Ruthenium; Triazoles; Vancomycin | 2013 |
Management of a case of Candida endogenous endophthalmitis in a neonate.
Topics: Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia; Candida tropicalis; Candidemia; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Infant, Newborn; Intravitreal Injections; Pyrimidines; Triazoles; Vancomycin; Voriconazole | 2014 |
Combination therapy with iron chelation and vancomycin in treating murine staphylococcemia.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Load; Benzoates; Chelating Agents; Deferasirox; Disease Models, Animal; Drug Therapy, Combination; Iron; Kidney; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Severity of Illness Index; Spleen; Staphylococcal Infections; Treatment Outcome; Triazoles; Vancomycin | 2014 |
Membrane active vancomycin analogues: a strategy to combat bacterial resistance.
Topics: Animals; Bacteremia; Cell Membrane Permeability; Drug Resistance, Bacterial; Enterococcus; Female; HeLa Cells; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Neutropenia; Quaternary Ammonium Compounds; Staphylococcal Infections; Staphylococcus; Structure-Activity Relationship; Triazoles; Vancomycin | 2014 |
Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma.
Topics: Animals; Atropine; Captopril; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Flutamide; Lamivudine; Liver; Male; Mannitol; Metabolomics; Methotrexate; Neomycin; Oxidative Stress; Phenytoin; Piperazines; Propylthiouracil; Rats; Rats, Wistar; Streptomycin; Triazoles; Valproic Acid; Vancomycin; Zidovudine | 2014 |
Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]-Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE.
Topics: Anti-Bacterial Agents; Click Chemistry; Enterococcus; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Structure-Activity Relationship; Triazoles; Vancomycin; Vancomycin Resistance | 2017 |
Treatment of Suspected Invasive Fungal Infection in War Wounds.
Topics: Administration, Topical; Afghan Campaign 2001-; Amphotericin B; Antifungal Agents; beta-Cyclodextrins; Debridement; Excipients; Humans; Mycoses; Recurrence; Risk Factors; Tobramycin; Treatment Outcome; Triazoles; Vancomycin; Voriconazole; Wounds and Injuries | 2018 |
Primary cutaneous mucormycosis of the abdomen at the site of repeated insulin injections.
Topics: Abdomen; Aged; Anti-Bacterial Agents; Antifungal Agents; Dermatomycoses; Diabetes Mellitus, Type 2; Female; Humans; Immunocompromised Host; Injection Site Reaction; Injections, Subcutaneous; Insulin; Lung Neoplasms; Mucormycosis; Necrosis; Nitriles; Pyridines; Triazoles; Vancomycin | 2020 |
Comparison of solithromycin with erythromycin in Enterococcus faecalis and Enterococcus faecium from China: antibacterial activity, clonality, resistance mechanism, and inhibition of biofilm formation.
Topics: Anti-Bacterial Agents; Biofilms; China; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Linezolid; Macrolides; Microbial Sensitivity Tests; Triazoles; Vancomycin | 2021 |